Videos and Podcasts
4th
Jun 21
Virtual Investor Briefing - 4 June 2021
Watch a recording of the Pharmaxis virtual investor briefing by the chief executive officer Mr Gary Phillips on Friday 4 June 2021.
Watch recording here.
4th
May 21
Pharmaxis drug to be focus of new brain cancer study with grant from Charlie Teo Foundation
Pharmaxis Ltd's (ASX:PXS) (FRA:UUD) CEO Gary Phillips tells Proactive's Andrew Scott its drug PXS-5505 will be the focus of a new study, funded by a grant from the Charlie Teo Foundation, looking at an aggressive and deadly form of brain cancer. The drug, which has commenced a phase 1/2a clinical trial for the rare bone marrow cancer myelofibrosis, will now enter pre-clinical efficacy testing for glioblastoma (GBM), the most common form of brain cancer with an average survival of only 15 months from diagnosis.
Watch the interview here.
3rd
May 21
Chanel Nine News Report: Pharmaxis and Charlie Teo Foundation Identify Promising New Drug to Tackle Brain Cancer
View the Channel Nine news Report here.